Global Top 10 Biotechnology Companies -- Industry, Financial and SWOT Analysis

리서치사	Datamonitor
발행일	2009년 07월	상품코드	101026
페이지 정보	105 pages
가격	US $ 1,895 ￦ 2,257,800 PDF by E-mail (Single User License) US $ 4,738 ￦ 5,645,300 PDF by E-mail (Global Site License)

한글목차
영문목차
관련자료

영문목차

Abstract

Scope:

‘Top 10 Global Biotechnology Companies Report: Strategic evaluation of industry and key players' is a business report that provides a comprehensive view of the global biotechnology industry and its top 10 companies.

The report includes the following:

Industry analysis including market value, market volume, market share and forecast growth till 2012
Assessment of intensity of competition based on five-forces model including degree of rivalry, substitutes, new entrants, buyer power and supplier power
SWOT and 5-year financial analysis of top 10 players in the industry
Descriptive profiles of the leading players including the strategic initiatives undertaken by them in the last 12 months

The top 10 companies have been ascertained based on their global revenues for the financial year 2008.

Highlights:

The global biotechnology market generated total revenues of $171.8 billion in 2007, representing a compound annual growth rate (CAGR) of 10.7% for the period spanning 2003 - 07. The performance of the market is forecast to decelerate, with an anticipated CAGR of 9.9% for the five-year period 2007 - 12, which is expected to drive the market to a value of $275.8 billion by the end of 2012.

The top 10 global biotechnology companies recorded revenues of $56.7 billion during 2008, an increase of 12.6% over FY2007. The operating profit of these companies was $15.1 billion in FY2008, an increase of 12.1% over FY2007. The net profit was $10.5 billion during FY2008, an increase of 10.3% over FY2007.

The average operating margin of the top 10 companies was 17% in FY2008 as compared with that of 20.2% in FY2007. The net margin was 10.3% in 2008 as compared with that of 14.9% in 2007.

Since 2003, the global biotechnology market has witnessed a significant growth across different geographies. However, the market growth is expected to decelerate for next few years due to increased number of patent expiries and intensifying competition from biosimilars.

Reasons to Purchase

Gain insights into the industry, leading companies and competitors through a single report
Benchmark the leading players using 5-year financial analysis, ratios and adjusted financial statement data
Form opinions about key players using SWOT Analysis to understand internal factors (strengths and weaknesses) and external factors (opportunities and threats) influencing the companies
Determine industry attractiveness from five-forces analysis of constituent segments.

Executive Summary
Industry analysis
Industry definition
Research highlights
Top 10 companies landscape
Market Value
Market Forecast
Market Segmentation - Product
Market Segmentation - Geographic
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Substitutes
Rivalry
Top 10 Companies Landscape
Revenue analysis
Financial performance analysis
Company Reports
Amgen
Genentech
Gilead Sciences
UCB
Genzyme
Biogen Idec
CSL
Celgene
Cephalon
Actelion
Financial Analysis
Amgen
Genentech
Gilead Sciences
UCB
Genzyme
Biogen Idec
CSL
Celgene
Cephalon
Actelion
Appendix

FIGURES

Figure 1: Global biotechnology market, $ million, 2003 - 07
Figure 2: Global biotechnology market forecast, $ million, 2007 - 12
Figure 3: Global biotechnology market segmentation - product, % share, 2007
Figure 4: Global biotechnology market segmentation - geography, % share, 2007
Figure 5: Forces driving competition in the global biotechnology market
Figure 6: Drivers of buyer power in the global biotechnology market
Figure 7: Drivers of supplier power in the global biotechnology market
Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology market
Figure 9: Factors influencing the threat of substitutes in the global biotechnology market
Figure 10: Drivers of degree of rivalry in the global biotechnology market
Figure 11: Revenues of global top 10 biotechnology companies, $ million, FY2008
Figure 12: Revenue growth of global top 10 biotechnology companies, 2006 - 08
Figure 13: Operating performance analysis, FY2008
Figure 14: Net profit analysis, FY2008

TABLES

Table 1: Global biotechnology market, $ million, 2003 - 07
Table 2: Global biotechnology market forecast, $ million, 2007 - 12
Table 3: Global biotechnology market segmentation - product , % share, 2007
Table 4: Global biotechnology market segmentation - geography, % share, 2007
Table 5: Revenues of global top 10 biotechnology companies, $ million, FY2008
Table 6: Revenue growth of global top 10 biotechnology companies, 2006 - 08
Table 7: Key financials of global top 10 biotechnology companies, FY2008
Table 8: Key industry specific ratios, FY2008
Table 9: Amgen - Financial and operational highlights, 2004 - 08 ($ million)
Table 10: Amgen - Key industry specific ratios, 2004 - 2008
Table 11: Genentech - Financial and operational highlights, 2004 - 08 ($ million)
Table 12: Genentech - Key industry specific ratios, 2004 - 08
Table 13: Gilead Sciences - Financial and operational highlights, 2004 - 08 ($ million)
Table 14: Gilead Sciences - Key industry specific ratios, 2004 - 08
Table 19: UCB - Financial and operational highlights, 2004 - 08 ($ million)
Table 20: UCB - Key industry specific ratios, 2004 - 08
Table 15: Genzyme - Financial and operational highlights, 2004 - 08 ($ million)
Table 16: Genzyme - Key industry specific ratios, 2004 - 08
Table 17: Biogen Idec - Financial and operational highlights, 2004 - 08 ($ million)
Table 18: Biogen Idec - Key industry specific ratios, 2004 - 08
Table 21: CSL - Financial and operational highlights, 2004 - 08 ($ million)
Table 22: CSL - Key industry specific ratios, 2004 - 08
Table 23: Celgene - Financial and operational highlights, 2004 - 08 ($ million)
Table 24: Celgene - Key industry specific ratios, 2004 - 08
Table 25: Cephalon - Financial and operational highlights, 2004 - 2008 ($ million)
Table 26: Cephalon - Key industry specific ratios, 2004 - 08
Table 27: Actelion - Financial and operational highlights, 2004 - 08 ($ million)
Table 28: Actelion - Key industry specific ratios, 2004 - 08